We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
4851
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$237K ﹤0.01%
36,082
+24,960
+224% +$139K
FRAF icon
4852
Franklin Financial Services
FRAF
$284M
$236K ﹤0.01%
9,125
+3,023
+50% +$78.1K
EMX
4853
DELISTED
EMX Royalty
EMX
$235K ﹤0.01%
108,808
+47,608
+78% +$84.7K
SYRE icon
4854
Spyre Therapeutics
SYRE
$8.54B
$235K ﹤0.01%
1,019
+881
+638% +$168K
KRYS icon
4855
Krystal Biotech
KRYS
$10.1B
$234K ﹤0.01%
5,642
+3,411
+153% +$164K
DBB icon
4856
Invesco DB Base Metals Fund
DBB
$312M
$233K ﹤0.01%
17,106
+5,663
+49% +$72.7K
EPU icon
4857
iShares MSCI Peru and Global Exposure ETF
EPU
$537M
$233K ﹤0.01%
8,181
-4,725
-37% -$125K
TYME
4858
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$233K ﹤0.01%
174,997
+27,220
+18% +$37.1K
BNTC icon
4859
Benitec Biopharma
BNTC
$402M
$232K ﹤0.01%
1,726
+601
+53% +$81.2K
CTBI icon
4860
Community Trust Bancorp
CTBI
$1.42B
$232K ﹤0.01%
7,107
-15,604
-69% -$502K
MBIO icon
4861
Mustang Bio
MBIO
$4.32M
$232K ﹤0.01%
98
+7
+8% +$16.4K
MCB icon
4862
Metropolitan Bank Holding Corp
MCB
$1.15B
$232K ﹤0.01%
7,237
+3,589
+98% +$95.4K
SAMG icon
4863
Silvercrest Asset Management
SAMG
$79M
$232K ﹤0.01%
18,292
+2,279
+14% +$24.2K
CRD.A icon
4864
Crawford & Co Class A
CRD.A
$532M
$231K ﹤0.01%
29,279
+3,021
+12% +$20.5K
EVLO
4865
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$231K ﹤0.01%
2,363
+32
+1% +$2.8K
BSX.PRA
4866
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
$230K ﹤0.01%
+2,210
New +$237K
SRLP
4867
DELISTED
SPRAGUE RESOURCES LP
SRLP
$230K ﹤0.01%
14,554
-14,957
-51% -$212K
LACQW
4868
DELISTED
Leisure Acquisition Corp. Warrant
LACQW
$230K ﹤0.01%
247,382
-140,763
-36% -$57.5K
RAPT
4869
DELISTED
RAPT Therapeutics
RAPT
$229K ﹤0.01%
990
+963
+3,567% +$149K
ASC icon
4870
Ardmore Shipping
ASC
$710M
$228K ﹤0.01%
52,448
+26,561
+103% +$142K
FKU icon
4871
First Trust United Kingdom AlphaDEX Fund
FKU
$38.7M
$227K ﹤0.01%
7,768
-869
-10% -$23.9K
SPWH icon
4872
Sportsman's Warehouse
SPWH
$44.5M
$227K ﹤0.01%
15,895
+10,887
+217% +$102K
ELOX
4873
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$227K ﹤0.01%
1,874
+5
+0.3% +$566
DHIL
4874
DELISTED
Diamond Hill
DHIL
$226K ﹤0.01%
1,979
+1,181
+148% +$124K
IDX icon
4875
VanEck Indonesia Index ETF
IDX
$32.1M
$225K ﹤0.01%
13,926
-2,118
-13% -$31.5K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.